Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Stover

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Journal of Racial and Ethnic Health Disparities|December 1, 2023
Low Hospital Volume Is Associated with Higher All-Cause Mortality in Black Women with Triple Negative Breast CancerSamilia Obeng-Gyasi, Demond Handley, Mohamed I Elsaid, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cellsBrian Bierie, Sarah E Pierce, Cornelia Kroeger, et al.
Annals of Surgical Oncology|May 8, 2026
Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by AgeSara P Myers, Yevgeniya Gokun, Brandon Slover, et al.
Annals of Surgical Oncology|May 25, 2026
ASO Visual Abstract: Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by AgeSara P Myers, Yevgeniya Gokun, Brandon Slover, et al.
Journal of the National Cancer Institute|November 20, 2024
Proinflammatory dietary pattern and risk of total and subtypes of breast cancer among US womenAndrea Romanos-Nanclares, Walter C Willett, Bernard Rosner, et al.
Plos Biology|August 30, 2018
BRAF and AXL oncogenes drive RIPK3 expression loss in cancerAyaz Najafov, Ioannis K Zervantonakis, Adnan K Mookhtiar, et al.
Cancers|September 14, 2024
The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast CancerDavid Han, Jonathan M Spehar, Dillon S Richardson, et al.
Cardio-Oncology (London, England)|December 9, 2020
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Jasmine Sukumar, Mahmoud Kassem, et al.
JCO Oncology Practice|September 21, 2022
Patient Understanding of Tumor Genomic Testing: A Quality Improvement EffortLeigha Senter, Deloris Veney, Taylor Surplus, et al.
Clinical Breast Cancer|August 28, 2019
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast CancerJonathan Wilkie, M Alexandra Schickli, Michael J Berger, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Journal of Racial and Ethnic Health Disparities|December 1, 2023
Low Hospital Volume Is Associated with Higher All-Cause Mortality in Black Women with Triple Negative Breast CancerSamilia Obeng-Gyasi, Demond Handley, Mohamed I Elsaid, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2017
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cellsBrian Bierie, Sarah E Pierce, Cornelia Kroeger, et al.
Annals of Surgical Oncology|May 8, 2026
Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by AgeSara P Myers, Yevgeniya Gokun, Brandon Slover, et al.
Annals of Surgical Oncology|May 25, 2026
ASO Visual Abstract: Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by AgeSara P Myers, Yevgeniya Gokun, Brandon Slover, et al.
Journal of the National Cancer Institute|November 20, 2024
Proinflammatory dietary pattern and risk of total and subtypes of breast cancer among US womenAndrea Romanos-Nanclares, Walter C Willett, Bernard Rosner, et al.
Plos Biology|August 30, 2018
BRAF and AXL oncogenes drive RIPK3 expression loss in cancerAyaz Najafov, Ioannis K Zervantonakis, Adnan K Mookhtiar, et al.
Cancers|September 14, 2024
The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast CancerDavid Han, Jonathan M Spehar, Dillon S Richardson, et al.
Cardio-Oncology (London, England)|December 9, 2020
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Jasmine Sukumar, Mahmoud Kassem, et al.
JCO Oncology Practice|September 21, 2022
Patient Understanding of Tumor Genomic Testing: A Quality Improvement EffortLeigha Senter, Deloris Veney, Taylor Surplus, et al.
Clinical Breast Cancer|August 28, 2019
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast CancerJonathan Wilkie, M Alexandra Schickli, Michael J Berger, et al.
Pageof 15